Seven hopeful dementia breakthroughs reshape diagnosis and treatment
TL;DR Summary
A Washington Post Well+Being piece highlights seven hopeful advances in dementia research and care—from new blood tests detecting amyloid and tau to improved drug delivery—suggesting earlier, more accurate diagnosis and better treatment options as dementia risk rises (about 42% lifetime after age 55 with projections of up to 1 million new cases per year by 2060).
- 7 surprisingly hopeful things we’ve learned about dementia The Washington Post
- A First: Gauging Alzheimer’s Prevalence from Blood Test Alzforum
- AFTD Webinar: Neurodegenerative Disease Biomarkers: What can they tell us about FTD? AFTD - The Association for Frontotemporal Degeneration
- Enhancing Biomarker Use and Targeted Treatment Approaches in Alzheimer Disease: Aaron Burstein, PharmD Neurology Live
- NeuroVoices: Nicholas Ashton, PhD, on Advances and Challenges in Alzheimer Disease Biomarkers Neurology Live
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
26 min
vs 26 min read
Condensed
99%
5,157 → 56 words
Want the full story? Read the original article
Read on The Washington Post